Long-Term Assets: The sum of all assets classified as non-current.
Nuvation Bio Inc. (NUVB) had Long-Term Assets of $23.30M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$62.90M |
|
$-204.63M |
|
$9.30M |
|
$53.60M |
|
$275.97M |
|
$-213.06M |
|
$8.44M |
|
$-204.63M |
|
$-204.59M |
|
$-204.63M |
|
$-204.63M |
|
$-204.63M |
|
$-204.59M |
|
$-213.06M |
|
$-210.66M |
|
341.54M |
|
341.54M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$571.52M |
|
$0.56M |
|
|
Long-Term Assets |
$23.30M |
$594.82M |
|
$82.23M |
|
$47.21M |
|
$206.88M |
|
$289.11M |
|
$305.72M |
|
$294.50M |
|
$305.72M |
|
346.50M |
|
| Cash Flow Statement Financials | |
$-173.43M |
|
$99.52M |
|
$202.53M |
|
$35.72M |
|
$164.09M |
|
$128.36M |
|
$35.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.95 |
|
-- |
|
-- |
|
0.13 |
|
0.17 |
|
85.22% |
|
-338.72% |
|
-338.72% |
|
-334.91% |
|
-325.31% |
|
-325.31% |
|
$-173.78M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.81 |
|
3.25 |
|
112.35 |
|
-66.93% |
|
-69.48% |
|
-34.40% |
|
-57.98% |
|
$0.88 |
|
$-0.51 |
|
$-0.51 |
|